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ABSTRACT
Background and aim The cost-effectiveness of internet-based smoking cessation interventions is difficult to determine
when they are provided as a complement to current smoking cessation services. The aim of this study was to evaluate the
cost-effectiveness of such an alternate package compared with existing smoking cessation services alone (current pack-
age). Methods A literature search was conducted to identify internet-based smoking cessation interventions in the
Netherlands. A meta-analysis was then performed to determine the pooled effectiveness of a (web-based) computer-
tailored intervention. Themean cost of implementing internet based interventions was calculated using available informa-
tion, while intervention reach was sourced from an English study. We used EQUIPTMOD, a Markov-based state-transition
model, to calculate the incremental cost-effectiveness ratios [expressed as cost per quality-adjusted life years (QALYs)
gained] for different time horizons to assess the value of providing internet-based interventions to complement the current
package.). Deterministic sensitivity analyses tested the uncertainty around intervention costs per smoker, relative risks,
and the intervention reach. Results Internet-based interventions had an estimated pooled relative risk of 1.40; average
costs per smoker of €2.71; and a reach of 0.41% of all smokers. The alternate package (i.e. provision of internet-based in-
tervention to the current package) was dominant (cost-saving) compared with the current package alone (0.14 QALY
gained per 1000 smokers; reduced health-care costs of €602.91 per 1000 smokers for the life-time horizon). The alternate
package remained dominant in all sensitivity analyses. Conclusion Providing internet-based smoking cessation inter-
ventions to complement the current provision of smoking cessation services could be a cost-saving policy option in the
Netherlands.
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INTRODUCTION
In order to reduce the impact of smoking (which is related
to various smoking-related diseases such as lung cancer,
heart diseases and stroke), the Framework Convention on
Tobacco Control (FCTC) was signed in 2003 by the World
Health Organization (WHO) and many countries, includ-
ing the Netherlands, with the aim to tackle the conse-
quences of tobacco smoking in the European Community
at all levels [1]. World-wide, each year tobacco smoking is
associated with more than 5 million deaths which are
attributable to direct smoking [2]. Moreover, as a result of
second-hand smoke, it is estimated that smoking leads to
at least 600000 additional deaths among non-smokers
each year in the world [2]. In the Netherlands alone,
19000 deaths were attributable to smoking-related dis-
eases in 2013 [3]. Smoking also represents a substantial
economic burden for society, with estimated costs of
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smoking tobacco being just above 1% of the European
Union gross domestic product in 2000 [4]. Hence, many
smoking cessation interventions have been developed
[5–7]; maximizing implementation of these interventions
can save more life-years and provide greater economic
benefits than most medical interventions for smoking-
related diseases [8]. Many cessation interventions have
been shown to be effective, especially the more intensive
interventions, such as one-to-one behavioural therapy
[9]. These interventions, however, are often expensive,
inconvenient for the recipient (e.g. waiting-list and the
need to take time off work) and reach only a small propor-
tion of smokers [10].
Internet-based interventions are relatively new innova-
tions and have the potential to reach many smokers due to
low costs per smoker, their accessibility (e.g. home, work
and public access points) and their availability 24 hours a
day [10]. More andmore people have access to the internet
world-wide, with approximately 94% of the Dutch popula-
tion as a whole and 98.6% of the youngsters (i.e. aged be-
tween 12 and 25 years) [11,12]. Especially for youngsters,
the internet provides opportunities, as some existing
smoking cessation interventions, such as nicotine replace-
ment therapy (NRT), are underutilized in this group [13].
An internet-based intervention has opportunities to be in-
teractive and provide tailored messages to individuals,
which has been shown to be effective in changing health
behaviours, including enhancing smoking cessation [14].
A Cochrane review, however, showed inconsistent results
[10]. Recently, internet-based interventions have been
shown to be effective for smoking cessation [15,16]. Many
effective internet-based interventions in the Netherlands
were individually computer-tailored interventions, where
health messages are tailored to input provided by the
smokers via questionnaires [10,15,17]. Due to low costs
per person and high reach, these interventions have a
reasonable chance to be cost-effective even if the effect size
is small [18]. Cost-effectiveness information is used
increasingly to inform policymaking, as budget holders
need to know whether societal benefits of interventions
are worth the investments. To our knowledge, no study
has yet estimated to what extent these internet-based
interventions are cost-effective when they are used to
complement the current provision of smoking cessation
interventions [19]. The aim of this study was therefore to
evaluate the cost-effectiveness of this alternate practice in
the Netherlands.
METHODS
While evidence of the effectiveness of digital mobile appli-
cations in general is less robust due to large heterogeneity
[20], it was deemed important to identify specific types
and elements of on-line interventions that could drive the
effectiveness. Therefore, a separate literature search and
review were conducted first to identify effective on-line
smoking cessation interventions that were relevant specif-
ically to the Dutch context. A meta-analysis was then
performed to determine the pooled effectiveness of
internet-based interventions. Secondly, we used a return
on investment tool, the EQUIPTMOD, a Markov-based
state-transition model developed by the European study
on Quantifying Utility of Investment in Protection from To-
bacco (EQUIPT), to assess the economic value of smoking
cessation interventions in five European countries, includ-
ing the Netherlands [21]. Themodel allowed us to consider
internet-based interventions to complement the current
package and thus we were able to compare this alternative
package to the current provision of smoking cessation ser-
vices in the Netherlands. For this, EQUIPTMOD required us
to specify effectiveness, costs and reach of internet-based
interventions, keeping all other interventions in the model
at their current levels of input estimates. As EQUIPTMOD is
designed to allow a ‘mix and match’ of various interven-
tions to create an alternative package, it was assumed that
the cost and effectiveness of existing services would remain
unchanged once internet-based smoking cessation inter-
ventions are included in the model. Input estimates (e.g.
costs, reach) used in the EQUIPTMOD are described else-
where [20,22]. A health-care perspective with different
time horizons (i.e. 2, 5 and 10 years and life-time) was used
in this study.
Literature search
This study focused on internet-based smoking cessation
interventions which are currently available in the
Netherlands.We therefore searched for interventions (final
inclusion criteria) that: (1) are internet-based, (2) are
directed at improving smoking cessation, (3) are Dutch,
either developed in the Netherlands or adapted from an
international internet-based intervention and (4) report
at least 12 months of follow-up using Dutch trial data. In
searching for these interventions, we began by exploring
a systematic review by Cochrane [10]—regarding the ef-
fectiveness of internet-based interventions—to screen for
the Dutch interventions. As the review was last updated
in 2013, we then conducted an additional systematic liter-
ature search up to July 2016 to explore recent internet-
based smoking cessation interventions in the Netherlands.
Similar to the Cochrane review [10], we based our
search strategy on the specialized register of the Cochrane
Tobacco Addiction Group, including the terms ‘internet’,
‘www’, ‘web’, ‘net’ or ‘online’ in the title, abstract or as key-
words, between January 2013 and July 2016. Databases of
Cochrane Central Register of Controlled trials (CENTRAL),
MEDLINE and EMBASE were searched via OVID. For full
search strategies, see the Tobacco Addiction GroupModule
88 Kei-Long Cheung et al.
© 2017 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction. Addiction, 113 (Suppl. 1), 87–95
[23]. The search led to a total of 651 papers (CEN-
TRAL = 96; MEDLINE = 163; and EMBASE = 392), from
which two researchers (K.L.C. and B.W.) screened indepen-
dently for title and abstract. For the title and abstract
screening, the inclusion criteria were: (1) smoking cessa-
tion intervention, (2) eHealth [i.e. internet, mobile, short
messaging service (SMS) or computer] and (3) English or
Dutch language. The two researchers resolved disagree-
ments through discussion, resulting in 74 potentially
relevant papers. For the full-text screening, a fourth crite-
rion was added: studies needed to include effectiveness
values of 12-month follow-up, consistent with assump-
tions from the return on investment (ROI) model (see
economic model below). Life-style and prevention inter-
ventions were excluded. The authors searched through
the full text papers and the Cochrane review [10] for the
relevant Dutch interventions, which led to the selection
of five internet-based smoking cessation interventions
[15,17,24]. Further details on the literature search for
Dutch internet-based smoking cessation interventions are
provided elsewhere [25].
On-line smoking cessation intervention
The five included interventions on the effectiveness or cost-
effectiveness of on-line smoking cessation interventions
were similar [15,17,24]; all were computer-tailored inter-
ventions and based on the Integrated Change (I-Change)
model [15,26–28]. As described in a recent systematic re-
view in the Netherlands, all Dutch internet-based smoking
cessation interventions (with a follow-up of 12 months)
were shown to be effective and incorporated messages
tailored to the individual [25]. Computer tailoring is an
effective technique for health education and combines in-
formation or change strategies to the outcome of interest.
The information or change strategies used are intended
to reach one specific person and are based on individual-
specific characteristics derived from individual assessment
[29,30]. Hence, computer-tailored messages are
personalized, which attracts attention and includes less
unnecessary information than non-tailored materials
[31]. Consequently, compared to non-tailored materials,
computer-tailored messages are better read, saved, memo-
rized and discussed with others [14,32,33]. The I-Change
model has been used for several previous studies investigat-
ing the determinants of adopting a smoking cessation
intervention [34–37]. The I-Change model integrates con-
cepts of various cognitive models, such as Ajzen’s Theory of
Planned Behaviour [38] and the Health Belief Model [39].
The intention is assumed to be an immediate antecedent of
behaviour [38]. The I-Change model explains the adoption
of health behaviour and health behavior-promoting poli-
cies in (at least) three phases (i.e. awareness, motivation
and action phase). Each phase has phase-specific
determinants, such as knowledge and risk perceptions for
understanding awareness; attitudes, social support and
self-efficacy for understanding motivation; and action
planning and skills to understand the final step from inten-
tions to behaviour. The web-based computer-tailored inter-
ventions from the included studies typically asked users to
complete an on-line questionnaire and to set a quit date.
The intervention then personalizes its feedback to the user
regarding demographic characteristics (e.g. gender) and
I-Change model constructs (e.g. attitude, social influence,
self-efficacy, intention to quit smoking, action planning
and smoking behaviour).
Relative risk, costs and reach of the pooled intervention
The economic model requires several input parameters re-
garding the internet-based smoking cessation interven-
tions, including the relative risk of smoker cessation (RR),
the costs per smoker per intervention and the reach. Given
the similarities of the included studies, we investigated the
impact of a web-based computer-tailored interventionwith
a pooled effect size. Effectiveness in terms of smoking cessa-
tion was expressed as abstinence rates at the 12-month
follow-up (using the most conservative cessation out-
comes). A meta-analysis was conducted for the five
included interventions, using the Mantel–Haenszel fixed-
effect model for the relative risk of the pooled intervention.
Abstinence rates and group sizes were obtained from all in-
terventions. This resulted in a pooled RRof 1.40 [95% con-
fidence interval (CI) = 1.18–1.66] (see forest plot in Fig. 1).
Moreover, while the random-effects model allows the study
outcomes to vary in a normal distribution between studies,
the I2 statistic (i.e. the percentage of variation across studies
due to heterogeneity) was zero (0.0%, P=0.83), indicating
the appropriateness of a fixed-effects model [40]. Annual
costs per respondent (smoker) were obtained where avail-
able [15,24], whichwere then averaged for the pooled costs
of €2.71 per person, ranging from €0.22 to 7.70. Costs at-
tributable to deliveryof the intervention (e.g. hosting for the
web-based intervention) were included, whereas research
and development costs (one-off costs) and promotional
costs were excluded. There is some indication fromUK data
that 1.4% of quit attempts involve website or smartphone
interventions [41]. This was multiplied to the percentage
of smokers intending to make a quit attempt in the next
12 months (29%) [42], resulting in an estimated reach of
0.41% of all smokers for on-line smoking cessation inter-
ventions. All these input estimates were changed in sensi-
tivity analyses to assess their impact on results.
Current package
The EQUIPTMOD includes by default top-level interven-
tions, behavioural support and pharmaceuticals in the
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current package. Top-level interventions increase the num-
ber of quit attempts, enhancing the use of cessation inter-
ventions. Top-level interventions included in the model
are social marketing and brief physician advice. Moreover,
taxation on tobacco and an indoor smoking ban in public
places are categorized as top-level interventions. In the
Netherlands, visits to a general practitioner (GP) are reim-
bursed [43],which guide the patients towards the cessation
support. The GP may prescribe behavioural support (i.e.
one-to-one behavioural support, group-based behavioural
support, telephone support, SMS text messaging or printed
self-help materials), and optionally pharmaceuticals (i.e.
single mono nicotine replacement therapy (mono NRT), a
combination of NRTs (combo NRT), varenicline (standard
duration or extended duration) or bupropion) [6,44]. Data
were derived from literature reviews and randomized con-
trolled trials regarding effectiveness and cost-effectiveness,
searched by the EQUIPT team [21]. Costs, effects and reach
of the current package are included in Table 1. A list of pa-
rameter sources is detailed elsewhere [45].
Economic model
We used the EQUIPTMOD, described elsewhere inmore de-
tail [22], which is a Markov-based state-transition cohort
model with a cycle length of 1 year. Smokers older than
16 years were included in the model in which there are
three health states: ‘smoker’, ‘former smoker’ and ‘death’.
Figure 1 Forest plot of the meta-analysis. Relative risk (RR) and its 95% confidence interval (CI)
Table 1 Costs, effects and reach of the interventions in current package.
Interventions Costs per smoker per intervention (€) Effecta Reach as % of smokersb
Top-level interventions
Brief physician advice 33.00 [62] 1.40 [63] 21.00
Pharmaceutical interventions
Rx mono nicotine Replacement (NRT) 225.05 [64] 1.60 [65] 5.00
Rx combo nicotine Replacement (NRT) 465.24 [64] 2.14 [65] 2.00
Varenicline (standard duration) 325.71 [64] 2.30 [66] 5.00
Varenicline (extended duration) 612.42 [64] 2.76 [67] 1.00
Bupropion 175.78 [64] 1.60 [68] 1.00
Behavioural interventions
Specialist behavioural support: one-to-one 465.00 [62] 1.40 [9] 2.00
Specialist behavioural support: group-based 41.90 [62] 2.00 [9] 1.00
Telephone support: proactive 119 [62] 1.40 [69] 0.50
SMS text messaging 23.68c 1.71 [61] 0.50
Printed self-help materials 1.21 [6] 1.19 [70] 1.00
aFor top-level interventions, effect is relative increase in the percentage of smokers making a quit attempt in the next 12 months. For pharmaceutical and
behavioural interventions effect is relative effect of a quit attempt to be successful versus an unassisted quit rate; breach was taken from England data; ccosts
are equated to England data. NRT = nicotine replacement therapy; SMS = short message service.
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A cohort of smokers enters the model in the smoker cate-
gory. On successful quit (predicted by reach and effective-
ness of cessation interventions), current smokers move to
the ‘former smoker’ state, and remain there for the first
year. Subsequent to the first year, a background quit rate
was applied in all years, which reflects the balance of quit-
ting and relapsing over the life-time of the cohort. The
model also includes an absorbing state, ‘death’, which is
predicted by age- and sex-specific mortality rates, adjusted
for smoking status. Two separate models were created to
simulate the effects on health of either quitting or not quit-
ting smoking during the first cycle of the model. The sepa-
rate models combine the results by weighting the outputs
of the models by the country-specific population and the
package effectiveness and reach. The model includes four
smoking-related diseases (i.e. lung cancer, coronary heart
disease, chronic obstructive pulmonary disease and stroke).
Utility values by smoking status and utility decrements
associated with these smoking-related diseases were
assigned to the relevant proportion of the cohort within
each state in order to estimate the QALYs. The input data
used in the model for the Netherlands included smoking
prevalence [46], relative risks of smoking-related diseases
[47–49], cost of smoking-related diseases [47,50] and the
background quit rate [51]. The list of parameter estimates
is detailed elsewhere [45].
Analysis
First, the pooled internet-based intervention was added to
the model as a behavioural support intervention, with its
relative risk, costs and reach estimates. Adding this inter-
vention into the model led to the creation of the alternate
package. We estimated the differences in costs and out-
comes between the alternate package and the current
package. Costs and average QALYs were calculated for
each time horizon (i.e. 2, 5 and 10 years and life-time).
To estimate whether the alternate package is cost-effective
compared to the current package, the incremental cost-
effectiveness ratio (ICER) expressed in costs per QALY
gained was calculated. The ICER represents the additional
cost of the alternate package compared with the current
package per QALY gained. If an intervention is associated
with higher QALYs and lower costs, it is said to be ‘cost-
saving’. Discount rates of 4.0 and 1.5%were used for costs
and effects, respectively [52]. Uncertainty around input es-
timates was investigated using deterministic sensitivity
analyses. A series of deterministic sensitivity analyses was
conducted for the life-time horizon to assess the impact
on the ICER of changes in RRs, costs and reach of the
pooled web-based computer-tailored intervention. The RR
of 1.39 varied from 1.18 to 1.65, based on its 95% CI. A
range of costs was used, varying from €0.22 to 7.70. Half
and double the reach estimate (0.41%) were used as lower
and upper bounds in the sensitivity analysis. A conserva-
tive cost-effectiveness threshold of €20000 was used
[53]. Furthermore, we conducted a threshold analysis to
estimate the cost (including promotional and implementa-
tion activities) at which internet-based smoking cessation
interventions yield cost-effective results. This was per-
formed by increasing the costs of the intervention per per-
son up to the point where net incremental benefit was zero.
RESULTS
Costs, average QALYs and ICERs
Costs and average QALYs for the current package and the
alternate package are shown in Table 2. Compared to the
current package, the alternate package was dominant for
all time horizons, i.e. the alternate package is associated
with more QALYs and lower costs. For instance, the alter-
native package dominated the current package with 0.14
QALY gained per 1000 smokers and reduced healthcare
costs of €602.91 per 1000 smokers for the lifetime horizon.
Sensitivity analyses
Sensitivity analyses were conducted, varying intervention
costs per smoker, RRs and reach for the life-time horizon
(see Table 3; sensitivity analyses using low and high ends
Table 2 Costs, QALYs and ICERs per 1000 smokers comparing alternative package versus current package.
Horizon
Average total costs




ratio (€ per QALY gain)
Current package 2 years 1 468 783.00 1611.13 –
5 years 3 507 385.08 3877.85 –
10 years 6 612 182.46 7260.26 –
Life-time 18301 798.23 20953.69 –
Alternative package 2 years 1 468 729.32 1611.13 Dominant
5 years 3 507 241.88 3877.86 Dominant
10 years 6 611 913.37 7260.29 Dominant
Life-time 18301 195.32 20953.83 Dominant
ICER = ; incremental cost-effectiveness ratio; QALYs = quality-adjusted life years.
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of the ranges). In all scenarios, the alternate package
remained dominant (higher QALYs, lower costs) compared
to the current package, withminor differences observed for
the average total costs and average QALYs. Note that the
average total costs per 1000 smokers changed with differ-
ent values of RRs and reach estimates, as different values of
effect size combined with different values of reach led
ultimately to different number of quitters and hence and
different treatment costs attributable to smoking-
attributable diseases. In addition, the annual maximum
costs per 1000 smokers that would be cost-effective to
spend on internet-based interventions were approximately
€149000.
DISCUSSION
This study showed that providing internet-based smoking
cessation interventions to complement the current provi-
sion of smoking cessation services is cost-saving in the
Netherlands, resulting in more QALYs gained at a lower
cost. The incremental costs per QALY gain were not sensi-
tive to the time horizon, the intervention costs per smoker,
RRs and the reach.
This study adds to the current literature that shows
that internet-based health promoting interventions may
have policy appeal. Our finding is comparable with a sys-
tematic review in that making internet-based interven-
tions available to smokers actively seeking to quit is
highly likely to be cost-effective [54].Whereas several stud-
ies have demonstrated that these interventions can be
effective and cost-effective, this study extended this body
of literature by showing explicitly the value of internet-
based interventions to complement the current provision
of smoking cessation interventions (i.e. this alternate
provision is less costly and more effective). Low average
costs to deliver these interventions is a notable driver of
cost-effectiveness [18].
Consistent with trial-based economic evaluations of
internet-based smoking cessation interventions
[15,17,24,55], this study showed some benefits of using
such interventions in the short term. It is important, how-
ever, to note that trial-based studies may not capture long
term cost-effectiveness, as the impact of cessation may
need longer than a 12-month follow-up to improve QALYs
of the ex-smokers [24,56]. It has therefore been suggested
that the impact of these interventions be evaluated using
longer time horizons [24]. This study is the first to incorpo-
rate a life-time horizon using a model to evaluate the cost-
effectiveness of internet-based interventions in the
Netherlands. Many other smoking cessation interventions
tend to be cost-effective well below the €25000 threshold
[6]. Internet-based interventions, if added to the current
provision of services, could be cost-saving compared to
the current practice alone. This seems to be due to low
costs per person to deliver these interventions, but an
observed high impact upon cessation outcome [18].
This study provides policymakers in the Netherlands
with the financial argument to implement and promote
internet-based smoking cessation interventions. Despite
previous evidence, the implementation of internet-based
interventions in the Netherlands has been limited, and
many are no longer publicly available [15,24]. Our findings
therefore provide an incremental approach to policy-
making in which internet-based interventions could be
used to complement the current package. Moreover, for
internet-based interventions to affect smoking behaviour,
it is important to enhance its reach by investing in promo-
tional and implementation activities. Although these costs
were excluded in our main analysis, the threshold analysis
indicated that an additional cost of up to €149/recipient on
promotional and implementation activities could be spent
to yield cost-effective results.
A few limitations of this study are worth mentioning.
First, given data gaps, the effectiveness estimates of the cur-
rent provision of interventions were derived from interna-
tional meta-analyses. While deriving the mean
effectiveness values, however, we considered the extent to
which such estimates were transferable to the
Netherlands. Secondly, while our analysis included poten-
tial increase in ‘within-model costs’ of implementing
Table 3 Sensitivity analysis: intervention costs per smoker, RRs and reach for life-time horizon.
Range
Average total costs




ratio (€ per QALY gain)
Current package – 18 301 798.23 20953.69 –
Base case (alternative package) 18 301 195.32 20953.83 Dominant
Intervention costs per smoker (€) 0.22 18 301 185.11 20953.83 Dominant
7.70 18 301 215.78 20953.83 Dominant
Relative risk 1.18 18 301 536.79 20953.75 Dominant
1.65 18 300 790.39 20953.93 Dominant
Reach (%) 0.20 18 301 499.72 20953.76 Dominant
0.81 18 300 604.17 20953.97 Dominant
RR = relative risk; QALY = quality-adjusted life years.
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internet-based interventions (i.e. intervention cost per per-
son), we acknowledge that there might be additional
potential ‘outside-model’ costs related to implementation
(e.g. cost of policy change such as changing guidelines
and promotion activities among local community health
services). Thirdly, this model incorporated the health-care
perspective, which may be considered as limiting in the
Netherlands [57,58]. Our estimates are therefore conserva-
tive, as work-place productivity is increased and absentee-
ism is decreased among former smokers compared to
current smokers [59]. This may lead to productivity gains
which decrease the societal burden. Fourthly, a probabilis-
tic sensitivity analysis (PSA), that addresses the uncer-
tainty around the model results by defining probability
distributions for the input estimates instead of point esti-
mates [60], could not be conducted, as the EQUIPTMOD
was developed primarily to underpin an ROI tool for
decision-making purposes [22]. This objective inevitably
required the model to have the restricted PSA functionality
(allowing a comparison between current and no invest-
ment only), thereby leading us to conduct a deterministic
sensitivity analysis instead for this purpose. Fifthly, while in-
cluding internet-based interventions in the model to com-
plement the current package, we assumed the costs and
effects of existing controlmeasures will remain unchanged.
It is reasonable to argue that provision of additional support
for quitting (in the form of internet-based interventions)
might lead to change in the costs and outcomes of existing
services. However, with no supporting data in hand it was
not possible to implement this argument into our analyses.
Finally, in this study only on-line tailored interventions
based on the I-Change model were identified as effective
in the long term in the Netherlands, while other types of in-
tervention may be available. This may thus not be general-
izable to general internet-based smoking cessations in a
global context. Hence, further investigation on the (cost-)
effectiveness of these other interventions is needed. More-
over, in everyday life the usage of mobile phones is becom-
ing increasingly important, indicating that internet-based
smoking cessation interventions (developed to be accessed
via a computer)may also need to function on amobile plat-
form. A Cochrane review indicated that no Dutch mobile
phone-based interventions were tested for their effective-
ness [61]. Hence, there may be a need to transfer effective
internet-based smoking cessation interventions to the mo-
bile phone-based platform. This creates opportunities for
future research to explore this issue, such as investigating
the differences in usage and effectiveness of interventions
between different platforms.
CONCLUSIONS
A policy to provide internet-based smoking cessation inter-
ventions to complement the current provision of smoking
cessation services in the Netherlands would be cost-saving
from a health-care perspective—it would reduce health-
care costs and result in QALY gains. Findings of this study
may therefore provide policy/decision-makers with
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